Taking into account that DAPK appeared to be silenced in HNSCC cells through DNA methylation long before the treatment with EGFR inhibitors, the Authors suggested DAPK as an epigenetic mediator in acquired resistance only in NSCLC but not in HNSCC cells (49). This evidence concerns the gene EGFR and non-small cell lung carcinoma.